Bradley Pharmaceuticals: Soars Share on CEO Acquisition Offer

| About: Bradley Pharmaceuticals (BDY)

In a 13D filing yesterday morning on Bradley Pharmaceuticals Inc. (BDY), President and CEO Daniel Glassman submitted a proposal to acquire all of the outstanding equity at a cash purchase price of $21.50 per share.

Bradley Pharmaceuticals confirmed the receipt of the bid and said they have formed a special committee to review the offer as well as other strategic alternatives.

Shares of BDY closed at $18.44 on Friday but jumped to $22.35 following the announcement yesterday.

BDY 1-yr chart

BDY

About this article:

Expand
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here